Statements (50)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:drug
|
gptkbp:affects |
central nervous system
muscarinic receptors |
gptkbp:appointed_by |
gptkb:Person
gptkb:skincare_product adults pregnant women elderly patients injection oral tablet |
gptkbp:contraindication |
gptkb:sneaker
gptkb:Insurance_Company urinary retention prostatic hypertrophy |
gptkbp:developed_by |
gptkb:jimson_weed
henbane |
gptkbp:discovered_by |
1833
|
gptkbp:excretion |
urine
|
https://www.w3.org/2000/01/rdf-schema#label |
scopolamine
|
gptkbp:ingredients |
C17 H20 N2 O4
|
gptkbp:is_available_on |
generic drug
brand name drug |
gptkbp:is_part_of |
pain management strategies
anesthetic protocols antiemetic therapy treatment regimen for motion sickness |
gptkbp:is_related_to |
atropine
hyoscine |
gptkbp:is_studied_in |
sleep disorders
anxiety reduction depression treatment cognitive effects |
gptkbp:is_used_for |
gptkb:healthcare_organization
nausea motion sickness |
gptkbp:is_used_in |
palliative care
treatment of motion sickness preoperative sedation |
gptkbp:marketed_as |
gptkb:Scopace
gptkb:Transderm_Scop gptkb:Buscopan gptkb:Hyoscine_Butylbromide |
gptkbp:metabolism |
liver
|
gptkbp:side_effect |
confusion
drowsiness dry mouth blurred vision |
gptkbp:type_of |
51-34-3
|
gptkbp:bfsParent |
gptkb:Sultan
|
gptkbp:bfsLayer |
3
|